Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Study ID: NCT07220356
Start Date: 2025-12-15
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

C-Raven Virtual Tobacco Cessation Counseling

Nicotine Replacement Product

Community Health Worker

Lung Cancer Screening

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Study ID: NCT06010329
Start Date: 2023-12-27
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Sutetinib Maleate Capsule

Sponsor

Read the US carefully

Source: clinicaltrials.gov

Share:
Add to list

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Study ID: NCT05956457
Start Date: 2023-09-15
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Digital Health Coaching Program

Fitbit

Sponsor

Pack Health

Source: clinicaltrials.gov

Share:
Add to list

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

Study ID: NCT06898957
Start Date: 2025-05-16
End Date: 2031-04-23
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

YL201

liquidatemab

Atezolizumab

Durvalumab

Sponsor

Amgen

Source: clinicaltrials.gov

Share:
Add to list

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

Study ID: NCT06517901
Start Date: 2025-04-18
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1306

Intervention / Treatment

Software fusion prostate biopsy

Cognitive fusion prostate biopsy

Sponsor

Albany Medical College

Source: clinicaltrials.gov

Share:
Add to list

A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation

Study ID: NCT06772181
Start Date: 2025-03-04
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

IM@Home Program

Medical Device Usage and Evaluation

Administration Questionnaire

Interview

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

Study ID: NCT05289687
Start Date: 2023-05-25
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Daratumumab / Hyaluronidase Injection

Daratumumab / Hyaluronidase Injection

Daratumumab / Hyaluronidase Injection

Daratumumab / Hyaluronidase Injection

Sponsor

Eastern Cooperative Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Study ID: NCT04637763
Start Date: 2021-05-26
End Date: 2025-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

CB-010

Cyclophosphamide

Fludarabine

Sponsor

Caribou Biosciences, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Study ID: NCT04071236
Start Date: 2020-10-14
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Avelumab

Biospecimen Collection

Bone Scan

Computed Tomography

Magnetic Resonance Imaging

Peposertib

Administration Questionnaire

Radium Ra 223 Dichloride

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Study ID: NCT05406232
Start Date: 2023-09-15
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Biopsy

Biospecimen Collection

Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list